Bacterial products recognized by TLRs, such as LPS, short-chain fatty acids (SCFA), and peptide chains, can activate the IL-23/IL-17 axis and promote the development of tumor (CRC) (70, 71). The gene discussed is IL17A; the disease is neoplasm.